SCYNEXIS, Inc. Accounts Receivable, Allowance for Credit Loss, Recovery
SCYNEXIS, Inc. (SCYX) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $0 for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-13.
Discontinued › Notes › and Others › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2015-11-13
- SCYNEXIS, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2015-09-30 was $0.00.
- SCYNEXIS, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2014-12-31 was -$75.00K.
- SCYNEXIS, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2014-09-30 was $0.00.
- SCYNEXIS, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2013-12-31 was $0.00.
| Period end | Accounts Receivable, Allowance for Credit Loss, Recovery 3 month | Accounts Receivable, Allowance for Credit Loss, Recovery 6 month | Accounts Receivable, Allowance for Credit Loss, Recovery 9 month | Accounts Receivable, Allowance for Credit Loss, Recovery 12 month |
|---|---|---|---|---|
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $0.00 10-Q · filed 2015-11-13 | ||
| 2015-06-30 | $0.00 10-Q · filed 2015-08-19 | |||
| 2014-12-31 | -$75.00K derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | -$75.00K derived: sum of 2 quarters · filed 2015-11-13 | $0.00 8-K · filed 2015-10-30 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $75.00K 10-Q · filed 2015-11-13 | ||
| 2014-06-30 | $75.00K 10-Q · filed 2015-08-19 | |||
| 2013-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | $0.00 derived: sum of 2 quarters · filed 2015-10-30 | $10.00K 8-K · filed 2015-10-30 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $10.00K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $10.00K 10-Q · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |